Emerging disease information at your fingertips.
Requested actions Be aware: Moderna and Pfizer created bivalent formulations of their mRNA COVID-19 vaccines. The bivalent vaccines target the original strain of SARS-CoV-2 and Omicron subvariants BA.4 and BA.5. United States Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the bivalent vaccines for use as a single booster dose. People can get … 09/02/22 Health Advisory: Bivalent Vaccine Booster for COVID-19
We continue to monitor the monkeypox outbreak in Washington and the United States. Report possible monkeypox cases immediately upon suspicion, as Washington State Department of Health (DOH) requires. Call . We will help you complete an intake form and review exposure guidelines to evaluate close contacts. Monkeypox is rare and not often seen in the United States. It can cause a rash … 07/26/22 Health Advisory: Monkeypox Update
7/21/2022 – Health Update – Monkeypox (MPV) testing and accessing vaccine for postexposure prophylaxis
Health Alerts, Advisories, and UpdatesThis information below is specifically for Physicians and other Healthcare Providers. Health Update – Monkeypox (MPV) testing and accessing vaccine for postexposure prophylaxis (PDF) To subscribe or unsubscribe to these updates via email, please email Tippy.Hartford@clark.wa.gov Health Alert: conveys the highest level of importance; warrants immediate action or attention.Health Advisory: provides … 7/21/2022 – Health Update – Monkeypox (MPV) testing and accessing vaccine for postexposure prophylaxis